Genomic Test Articles & Analysis: Older
3 articles found
ESMO updated its recommendations for NGS in advanced cancers this year, urging broader use of NGS in additional cancer types and the inclusion of tumor-agnostic biomarkers. The ESMO Precision Medicine Working Group (PMWG) first published its recommendations for when to use next-generation sequencing (NGS) in routine practice for patients with metastatic cancers in 20201. At that time, based ...
Clinicians can make better diagnostic and treatment decisions using the data obtained by next-generation sequencing (NGS) technologies. Breast cancers, for example, have typically been diagnosed using mammography, physical exam, and histology. Genetics became more significant after the discoveries of oncogenes and other biomarkers. Today, commercially available microarray-based tests enable more ...
It’s not often you lovingly hug a 450-pound piece of equipment, but if it makes your work life easier you show your appreciation. The CDS-5 helps lab technologists create consistent and reliable environments for their work regardless of the day-to-day variables, like the weather. Imagine the weather outside impacting your office work indoors. Sounds inconvenient, right? That used to be a ...